Companies › IDAC

IDAC 10-K & 10-Q changes, risk factors and insider trading

Iron Dome Acquisition I Corp. (also IDACU, IDACW) · Nasdaq · Blank Checks · CIK 2090441 · All filings on SEC.gov

Everything below is quoted or computed from Iron Dome Acquisition I Corp.'s public SEC filings. It is not a recommendation to buy or sell. Automated comparisons can contain errors; confirm with the original filing.

At a glance

0Form 4 filings reporting open-market purchases (last 180 days)
0Form 4 filings reporting open-market sales (last 180 days)

Jump to: Annual report (10-K) · Quarterly report (10-Q) · Insider transactions · 13F holders

What changed in the latest 10-K

Comparison not available: Not available: fewer than two 10-K filings on EDGAR to compare..

What changed in the latest 10-Q

Comparing 10-Q filed 2026-08-14 (period ending 2026-06-30) with 10-Q filed 2026-06-26 (period ending 2026-03-31).

Risk Factors (10-Q Part II, Item 1A)

0new paragraphs
0removed paragraphs
1reworded paragraphs
58 → 82words in section

The section in the latest 10-Q reads in full:

Investing in our securities involves a high degree of risk. In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in our Registration Statement on Form S-1 filed with the SEC on January 30, 2026, as amended, which could materially affect our business, financial condition, or future results. As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Registration Statement.

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Reworded

Paragraph as it now reads, with added and removed wording marked:

Investing in our securities involves a high degree of risk. In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in our Registration Statement on Form S-1 filed with the SEC on January 30, 2026, as amended, which could materially affect our business, financial condition, or future results. results.As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Registration Statement.
see in full comparison
Full comparison: every changed paragraph (1)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

Investing in our securities involves a high degree of risk. In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in our Registration Statement on Form S-1 filed with the SEC on January 30, 2026, as amended, which could materially affect our business, financial condition, or future results. results.As of the date of this Quarterly Report, there have been no material changes to the risk factors previously disclosed in the Registration Statement.

Management's Discussion & Analysis (MD&A) (10-Q Part I, Item 2)

7new paragraphs
1removed paragraphs
10reworded paragraphs
1,947 → 2,226words in section

Largest changes (selected automatically by length and topic keywords; quoted verbatim, no commentary)

Reworded topics: fine

Paragraph as it now reads, with added and removed wording marked:

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied.statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
see in full comparison
New text
“On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000, less deferred underwriting commission of $420,000.”
see in full comparison
New text
“The underwriter is entitled to a deferred underwriting commission of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), payable upon completion of the Business Combination. The deferred underwriting commission is subject to adjustment based on redemptions, if any, of Class A ordinary shares. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.”
see in full comparison
Reworded

Paragraph as it now reads, with added and removed wording marked:

Simultaneously with the closing of the Initial Public Offering, we (i) completed the private sale of 2,750,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $2,750,000 (the “Private Placement”). The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering. On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.
see in full comparison
New text
“Additionally, the underwriter is entitled to a fixed fee of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), for advisory fees payable upon completion of the Business Combination. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.”
see in full comparison
New text
“For the six months ended June 30, 2026, cash used in operating activities was $39,969, which consisted of net income of $629,213, offset by investment income on investments held in Trust of $656,771, change in the over-allotment option of $212,823 and the net change in assets and liabilities of $200,412.”
see in full comparison
Full comparison: every changed paragraph (18)

Green = added, red = removed. Unchanged paragraphs and tables are not shown. Read the complete text in the original filing.

Reworded

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied.statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Registration Statement on Form S-1 filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Reworded

We are a blank check company incorporated as a Cayman Islands exempted company on September 5, 2025 for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this Quarterly Report as our initial business combination. We have not selected any specific business combination target, and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. We intend to effectuate our initial business combination using cash from the proceeds of the initial public offering (the “Initial Public Offering”) and the sale of the private placement warrants (the “Private Placement”) and the proceeds of the sale of our securities in connection with our initial business combination (pursuant to any the forward purchase agreements, backstop or similar agreements we may enter into following the consummation of the Initial Public Offering or otherwise), our shares, debt or a combination of cash, equity and debt.

Reworded

We have neither engaged in in any operations nor generated any revenues to date. Our only activities from September 5, 2025 (inception) through MarchJune 31,30, 2026 were organizational organizational activities and those necessary to prepare for the Initial Public Offering. Following the Initial Public Offering, we will continue not to generate any operating revenues until after completion of our initial business combination. We will continue to generate non-operating non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and the Private Placement held in the Trust Account. There has been no significant change in our financial or trading position and no material adverse change has occurred since the date of our audited financial statements. After the Initial Public Offering, we will continue to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

Added

For the three and six months ended June 30, 2026, we had a net income of $629,213, which primarily includes $656,771 of income earned on cash held in Trust and change in fair value of overallotment option of $212,823, partially offset by formation and operating expenses of $240,381.

Removed

For the three months ended March 31, 2026, we had a net loss of $0.

Reworded

As of June 30, 2026, we had cash of $767,364 held outside the Trust Account and working capital of $1,086,331. Until the consummation of the Initial Public Offering, our only sources of liquidity were an initial purchase of shares of Class B ordinary shares, par value $0.0001 per share, by the Sponsor and a loan from the Sponsor, of up to $300,000 under an unsecured, non-interest bearing promissory note, which was repaid on May 18, 2026.

Reworded

Subsequent to the quarterly period covered by this Quarterly Report, onOn May 18, 2026, we consummated the Initial Public Offering of 15,000,000 Units (the “Public Units” and, with respect to the Class A ordinary shares and public warrants included in the Public Units, the “Public Shares”, and “Public Warrants”, respectively). The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $150,000,000.

Reworded

Simultaneously with the closing of the Initial Public Offering, we (i) completed the private sale of 2,750,000 warrants (the “Private Placement Warrants”) to the Sponsor at a purchase price of $1.00 per Private Placement Warrant, generating gross proceeds to the Company of $2,750,000 (the “Private Placement”). The Private Placement Warrants are identical to the Public Warrants sold in the Initial Public Offering. On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.

Added

On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units (the “Over-Allotment”). The closing of the issuance and sale of the additional Units (the “Over-Allotment Option Units”) occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000, less deferred underwriting commission of $420,000.

Reworded

In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Such Working Capital Loans would be evidenced by promissory notes. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of the notes may be converted into Class A ordinary shares of the post-business combination entity at a price of $10.00 per share at the option of the Sponsor. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the the Trust Account would be used to repay the Working Capital Loans. As of MarchJune 31,30, 2026, there was no amount outstanding under the Working Capital Loans.

Added

For the six months ended June 30, 2026, cash used in operating activities was $39,969, which consisted of net income of $629,213, offset by investment income on investments held in Trust of $656,771, change in the over-allotment option of $212,823 and the net change in assets and liabilities of $200,412.

Added

For the six months ended June 30, 2026 cash used in investing activities was $157,785,000, which consisted of the funds deposited into the Trust.

Added

For the six months ended June 30, 2026 cash provided by financing activities was $158,592,333, which consisted of the proceeds from the Initial Public Offering and private placement, partially offset by offering costs.

Reworded

As of theJune three months ended March 31,30, 2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K and did not have any commitments or contractual obligations.

Reworded

The Company granted the underwriter a 45-day option from the date of the Initial Public Offering to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering.Offering price, less underwriting discounts and commissions. On May 19, 2026, the underwriter partially exercised the over-allotment option for 700,000 Units. The closing of the Over-Allotment Option Units occurred on May 20, 2026. The issuance by the Company of 700,000 Over-Allotment Option Option Units at a price of $10.00 per unit generated total gross proceeds of $7,000,000.

Added

The underwriter is entitled to a deferred underwriting commission of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), payable upon completion of the Business Combination. The deferred underwriting commission is subject to adjustment based on redemptions, if any, of Class A ordinary shares. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.

Added

Additionally, the underwriter is entitled to a fixed fee of $4,500,000 in the aggregate (or $5,175,000 if the underwriter’s over-allotment option is exercised in full), for advisory fees payable upon completion of the Business Combination. As of June 30, 2026, $4,710,000 is included in deferred underwriting commission.

Reworded

The preparation of the unaudited condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements, and income and expenses during the periods periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of MarchJune 31,30, 20262026, we had the following critical accounting estimates: fair value of public and Decemberprivate 31, 2025, we did not have any critical accounting estimates.warrants..

IDAC insider buying and selling (Form 4)

Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.

No Form 4 stock transactions in this period.

Well-known investors holding IDAC (13F)

InvestorQuarterSharesReported value% of their 13FChange vs prior quarter
Millennium Management (Israel Englander) UNIT 02/27/20312026-06-30600,000$6.1M0.0%New position
Two Sigma Investments UNIT 02/27/20312026-06-30271,875$2.7M0.0%New position

13F reports are filed up to 45 days after quarter end and show long U.S. equity positions only; options positions are omitted here.

Coming soon: email alerts when IDAC files, watchlists and downloadable comparisons.